Stage IIA Skin Melanoma Treatment With ECHO-7 Oncolytic Virus Rigvir
Ingrīda Čēma(Riga East University Hospital), Pēteris Alberts(Maxygen (United States)), Tatjana Zablocka(Riga East University Hospital), Sergejs Isajevs(Riga East University Hospital), Regīna Kleina(Riga Stradiņš University), Simona Doniņa(Children's Clinical University Hospital), Agnija Rasa
Cited by 5
Related Papers
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
|Diabetologia|2002|259
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1
|Journal of Medicinal Chemistry|2002|211
The advent of oncolytic virotherapy in oncology: The Rigvir® story
|European Journal of Pharmacology|2018|179